Products for Research Use Only
RegisterLogin

TRK-IN-29

CAT: 0804-HY-161819Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-161819Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
TRK-IN-29 (Compound B31) is a second-generation TRK inhibitor (IC50: 9 nM, 0.6 nM, 18 nM, 5 nM, 6 nM for TRKAG595R, TRKAF589L, TRKAG667C, TRKA and TRKC respectively) . TRK-IN-29 inhibits the phosphorylation of TRKA. TRK-IN-29 has good antiproliferative activities against NTRK fusion positive cells. TRK-IN-29 has exellent plasma stability and moderate pharmacokinetic properties[1].
UNSPSC
12352005
Target
Trk Receptor
Type
Reference compound
Related Pathways
Neuronal Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/trk-in-29.html
Smiles
C[C@H](C1=CC(F)=CC=C1OCC(F)F)NC2=CC3=C(NN=C3N4N=CN=C4)C=C2
Molecular Formula
C19H17F3N6O
Molecular Weight
402.37
References & Citations
[1]Qiaohua Qin, et al. Discovery of novel indazole derivatives as second-generation TRK inhibitors. European Journal of Medicinal Chemistry. Available online 1 July 2024, 116640, et al.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-144451TRK-IN-12
HY-160166TRK-IN-26
HY-146521TRK-IN-15
HY-12327Trk-IN-1
HY-144423Trk-IN-10
HY-146519TRK-IN-14
HY-160165TRK-IN-25
HY-161179TRK-IN-27
HY-146522TRK-IN-16
HY-150561Trk-IN-20

Alternative Products

CatalogName
T210169-01TRK-IN-29
338192-01Trk A
PA1321-STrk-A
GTR18303659Trk Antibody
T212244-01TRK-IN-32
T211064-01TRK-IN-31
T209555-01TRK-IN-22
T87568-01TRK-IN-25
T63346-01TRK-IN-18
T62561-01TRK-IN-17

Popular Products